• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Research Brief: Older adults often prescribed meds linked to higher side effect risks

Bioengineer by Bioengineer
March 27, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Drugs with high-risk anticholinergic properties can lead to risks of developing serious adverse events, such as cognitive impairment, falls, dementia, and even mortality in older adults. Yet, relatively little is known about prescribing trends of high-risk anticholinergic medications in the United States of America.

Researchers in the University of Minnesota College of Pharmacy conducted a repeated cross-sectional analysis of the 2006-2015 National Ambulatory Medical Care Survey to understand more.

They found that physicians' prescribing behavior remained stable over time, and these drugs were prescribed in about six percent of visits over a ten-year period. The findings were recently published in the Journal of the American Geriatrics Society.

"High-risk anticholinergic prescribing should be avoided because there are safer alternative medications for older adults," said the lead study author, Greg Rhee, Ph.D., M.S.W., adjunct assistant professor in the College of Pharmacy.

Anticholinergic medications block the neurotransmitter acetylcholine, which is part of the nervous system and plays a role in involuntary muscle contractions. These drugs are often prescribed for urinary, respiratory and gastrointestinal disorders. They're also often used to treat depression.

"Older adults are vulnerable to these medications due in part to physiological changes as they age. In general, older adults have a higher likelihood of developing adverse drug events from taking multiple medications," Rhee said.

The research team investigated whether prescribing patterns of high-risk anticholinergic drugs have changed over time and whether these patterns vary by physician specialty and anticholinergic class among older adults in their office-based care. They also estimated demographic and clinical correlates factors independently associated with these high-risk anticholinergic medication prescriptions.

They found:

  • six percent of doctors' visits studied within the survey period listed an anticholinergic medication – suggesting he prescribing pattern varies by physician specialty (e.g., psychiatrists and urologists had higher rates of listing an anticholinergic medication);
  • that by medication class, antidepressants were the most prevalent among anticholinergic drugs prescribed to older adults;
  • women were more likely to receive high-risk anticholinergic prescriptions;
  • patients from the South were more likely to receive high-risk anticholinergic prescriptions;
  • patients with prescribed six or more medications had a greater likelihood of being prescribed high-risk anticholinergic prescriptions.

The research team acknowledged the study had limitations. The survey does not include emergency department or hospital visits. Therefore, the study results may actually underestimate the full impact.

Rhee noted that the prevalence of high-risk anticholinergic prescriptions was stable over time, but varied by physician specialty and drug class. He recommends increasing awareness of potential adverse effects and encouraging providers to prescribe less-risky medications.

###

Media Contact

University Relations
[email protected]
612-624-5551
@UMNews

http://www.umn.edu

https://twin-cities.umn.edu/news-events/research-brief-older-adults-often-prescribed-meds-linked-higher-side-effect-risks

Related Journal Article

http://dx.doi.org/10.1111/jgs.15357

Share12Tweet7Share2ShareShareShare1

Related Posts

Next-Gen Reference Intervals for Pro-GRP Revealed

September 3, 2025

Navigating Healthcare Funding Challenges in Iran

September 3, 2025

Comparing TV-46000 to Second-Gen Injectable Antipsychotics

September 3, 2025

Breakthroughs in Electrospun Nanofiber Composites for Enhanced Physical, Physiological, and Biofluid Signal Monitoring

September 3, 2025
Please login to join discussion

POPULAR NEWS

  • Needlestick Injury Rates in Nurses and Students in Pakistan

    297 shares
    Share 119 Tweet 74
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    118 shares
    Share 47 Tweet 30

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Next-Gen Reference Intervals for Pro-GRP Revealed

Uncovering Challenges in Social Bot Detection

Navigating Healthcare Funding Challenges in Iran

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.